BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17504182)

  • 1. Pharmacological therapy of Cushing's syndrome: drugs and indications.
    Díez JJ; Iglesias P
    Mini Rev Med Chem; 2007 May; 7(5):467-80. PubMed ID: 17504182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs in the medical treatment of Cushing's syndrome.
    Schteingart DE
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical therapy of Cushing's disease.
    Nieman LK
    Pituitary; 2002; 5(2):77-82. PubMed ID: 12675504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
    Engelhardt D; Weber MM
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
    Feelders RA; Hofland LJ; de Herder WW
    Neuroendocrinology; 2010; 92 Suppl 1():111-5. PubMed ID: 20829630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of hypercortisolism.
    Shalet S; Mukherjee A
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):234-8. PubMed ID: 18438170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New perspectives in the treatment of Cushing's syndrome.
    Labeur M; Arzt E; Stalla GK; Páez-Pereda M
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Dec; 4(4):335-42. PubMed ID: 15578985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
    Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological treatment in adrenal Cushing's syndrome.].
    Stigliano A; Cerquetti L; Toscano V
    Recenti Prog Med; 2016 Nov; 107(11):574-581. PubMed ID: 27869874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological management of Cushing's syndrome: an update.
    Dang CN; Trainer P
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1339-48. PubMed ID: 18209872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical usefulness of pharmacological treatment of Cushing's syndrome].
    Saito J; Nishikawa T
    Nihon Rinsho; 1994 Mar; 52(3):793-6. PubMed ID: 8164384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-dependent Cushing's syndrome in older people: presentation of five cases and therapeutical use of ketoconazole.
    Berwaerts JJ; Verhelst JA; Verhaert GC; Verhaegen AA; Abs RE
    J Am Geriatr Soc; 1998 Jul; 46(7):880-4. PubMed ID: 9670876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
    Colombo P; Passini E; Re T; Faglia G; Ambrosi B
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and treatment of Cushing's syndrome.
    Nieman LK; Ilias I
    Am J Med; 2005 Dec; 118(12):1340-6. PubMed ID: 16378774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for somatostatin and its analogs in Cushing's syndrome?
    de Herder WW; Lamberts SW
    Metabolism; 1996 Aug; 45(8 Suppl 1):83-5. PubMed ID: 8769391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopic production of ACTH and corticotropin-releasing hormone (CRH).
    Müller OA; von Werder K
    J Steroid Biochem Mol Biol; 1992 Oct; 43(5):403-8. PubMed ID: 1327073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates in adrenal steroidogenesis inhibitors for Cushing's syndrome - A practical guide.
    Varlamov EV; Han AJ; Fleseriu M
    Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101490. PubMed ID: 33707082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
    Lau D; Rutledge C; Aghi MK
    Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cushing's syndrome.
    Schteingart DE
    Endocrinol Metab Clin North Am; 1989 Jun; 18(2):311-38. PubMed ID: 2663477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.